
LifeTein supports peptide–lipid and LNP-related conjugation projects in which peptides are attached to lipids, PEG-lipids, or related delivery-facing scaffolds for nanoparticle formulation, targeting, uptake, or tracking studies. These projects often involve DSPE-PEG, cholesterol-PEG, DMG-PEG, clickable lipids, or related amphiphilic building blocks.
In many practical projects, the peptide is not being “encapsulated” by us into a finished LNP product. Instead, we usually support the upstream chemistry needed to generate a peptide-functionalized lipid or PEG-lipid building block that the customer can use in downstream nanoparticle formulation and evaluation.
| Peptide–PEG–lipid | Peptide linked to DSPE-PEG, DMG-PEG, cholesterol-PEG, or related PEG-lipid systems |
| Targeting peptides | Peptides designed to sit on the exterior of a nanoparticle-facing construct for receptor targeting or biodistribution studies |
| CPP or transport peptides | Peptide domains intended to enhance uptake or trafficking |
| Clickable lipids | Lipid constructs bearing azide, alkyne, DBCO, tetrazine, or related handles |
| Preferred routes | Maleimide–thiol PEG-lipid conjugation for many routine designs; click-compatible routes for orthogonal or multifunctional constructs |
For more detail on PEG-facing chemistry, see Peptide PEGylation Service. For broader conjugation options, see Peptide conjugation by click chemistry and site-selective ligation.
Reference note: Published work has used peptide-modified lipid systems in LNP-related delivery studies, including cyclic peptide-lipid constructs synthesized with N-terminal lipid modification strategies.
What we usually deliver
In most cases, we provide the peptide-functionalized lipid or PEG-lipid building block rather than a finalized clinical-grade LNP formulation.
Need a quote?